2017 Newsletters
Like what we’re doing? SUBSCRIBE to our newsletter and get our latest project updates and news information sent right to your inbox! Contact us for more information.
- Fodder: Final Nail in the Addyi Coffin?
- Fodder: Live from Capitol Hill: McCaskill Investigates Insys Marketing Practices
- Fodder: RxFiles: Drugs as Innocent Bystanders
- Fodder: RxFiles: When it comes to drug allergies: Is the allergy real?
- Fodder: RxFiles: When it comes to drug allergies: Time is money
- Fodder: Orphan Drugs: Pharma's New Favorite Child
- Fodder: RxFiles: Should Device Reps Be Involved in Anticoagulant Decisions?
- Fodder: Rx Files
- Fodder: Live at the FDA: Battling Off-Label Promotion